Pure Global

IVD supports the visualization of the DNP-labeled probe sequence in situ hybridization - Vietnam Registration 230000611/PCBA-HCM

Access comprehensive regulatory information for IVD supports the visualization of the DNP-labeled probe sequence in situ hybridization in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi A medical device is registered under number 230000611/PCBA-HCM and manufactured by Ventana Medical Systems, Inc..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
230000611/PCBA-HCM
Registration Details
Vietnam MOH Registration: 230000611/PCBA-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD supports the visualization of the DNP-labeled probe sequence in situ hybridization
VN: IVD hแป— trแปฃ hiแป‡n mร u ฤ‘oแบกn dรฒ ฤ‘รฃ ฤ‘รกnh dแบฅu DNP trong lai tแบกi chแป—
Risk Class TTBYT Loแบกi A

Registration Details

230000611/PCBA-HCM

000.00.19.H29-230523-0005

ultraView SISH DNP Detection Kit

05907136001

Company Information

UNITED STATES

Technical Details

The ultraView SISH DNP Detection Kit of Ventana Medical Systems Inc. (Ventana) is an indirect system, without biotin, for the detection of DNP-labeled probes. The kit is used to determine the targets by in situ hybridization (ISH) of silver-labeled probes on formalin-fixed, paraffin-embedded tissue sections on the BenchMark IHC/ISH instrument. The interpretation of the test results based on the coloration or non-coloration must be combined with histological evaluation and the assessment of appropriate tissue control samples (positive and negative controls). The evaluation of the results must be performed by a qualified interpreter, in combination with the patient's clinical history and other diagnostic tests. This detection kit is intended for in vitro diagnostic use (IVD).

Dates and Status

May 24, 2023